Skip to main content

Advertisement

SpringerLink
Log in

Papillary Thyroid Microcarcinoma: Reclassification to Non-Invasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features (NIFTP): a Retrospective Clinicopathologic Study

  • Published:
Endocrine Pathology Aims and scope Submit manuscript

Abstract

Papillary thyroid microcarcinoma (PTMC) accounts for nearly 50% of newly diagnosed PTC cases. There is considerable debate in literature about the clinicopathologic features and prognostic significance of PTMC and whether it should be treated as a separate entity. Due to lack of agreement and supportive data, the consensus study group that established the criteria for non-invasive thyroid neoplasm with papillary-like features (NIFTP) kept its size above 1 cm i.e., excluding PTMC from this new group. As a result, to date, some patients diagnosed with PTMC get aggressive treatments such as partial or total thyroidectomy and even radioactive iodine ablation. We retrospectively studied clinicopathologic features and long-term follow-up of 48 cases of papillary thyroid microcarcinoma. Of these, 7 cases (15%) had capsular invasion, 2 cases (4%) had extrathyroidal extension, 1 case (2%) had lymphovascular invasion, 5 cases (25%) had lymph node metastases, no case (0%) had any distant metastases, and 1 case had recurrence after long-term follow-up (mean 13.7 years, range 1–21 years). Upon slide review, 8 cases fulfilled the criteria for NIFTP and were sub-classified under this new category. These 8 cases had no recurrence after long-term follow-up (mean 12.1 years, range 7–19 years). In this study, we confirmed the previous published reports exhibiting indolent nature of PTMC and also suggested that PTMC cases that fulfill all the criteria for NIFTP can be sub-classified under this term in order to avoid unnecessary aggressive treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Soares P, Celestino R, Gaspar da Rocha A, Sobrinho-Simoes M. Papillary thyroid microcarcinoma: how to diagnose and manage this epidemic? Int J Surg Pathol. 2014;22(2):113–119.

    Article  Google Scholar 

  2. Xu B, Farhat N, Barletta JA, Hung YP, Biase D, Casadei GP, et al. Should subcentimeter non-invasive encapsulated, follicular variant of papillary thyroid carcinoma be included in the noninvasive follicular thyroid neoplasm with papillary-like nuclear features category? Endocrine. 2018;59(1):143–150.

    Article  CAS  Google Scholar 

  3. Uhliarova B, Hajtman A. Hashimoto's thyroiditis - an independent risk factor for papillary carcinoma. Braz J Otorhinolaryngol. 2017. https://doi.org/10.1016/j.bjorl.2017.08.012.

  4. Ito Y, Miyauchi A. Prognostic factors and therapeutic strategies for differentiated carcinomas of the thyroid. Endocr J. 2009;56(2):177–192.

    Article  Google Scholar 

  5. Liu C, Chen T, Zeng W, Wang S, Xiong Y, Liu Z, Huang T Reevaluating the prognostic significance of male gender for papillary thyroid carcinoma and microcarcinoma: a SEER database analysis. Sci Rep. 2017;7(1):11412.

    Article  Google Scholar 

  6. Gonzalez Bossolo A, Garcia MM, Gonzalez PJ, Garcia M, Villarmarzo G, Martinez JH. A new paradigm in low-risk papillary microcarcinoma: active surveillance. Endocrinol Diabetes Metab Case Rep. 2017. https://doi.org/10.1530/EDM-17-0065.

  7. Roti E, Rossi R, Trasforini G, Bertelli F, Ambrosio MR, Busutti L, Pearce EN, Braverman LE, degli Uberti EC Clinical and histological characteristics of papillary thyroid microcarcinoma: results of a retrospective study in 243 patients. J Clin Endocrinol Metab. 2006;91(6):2171–2178.

    Article  CAS  Google Scholar 

  8. Nikiforov YE, Seethala RR, Tallini G, Baloch ZW, Basolo F, Thompson LD, et al. Nomenclature Revision for Encapsulated Follicular Variant of Papillary Thyroid Carcinoma: A Paradigm Shift to Reduce Overtreatment of Indolent Tumors. JAMA Oncol. 2016;2(8):1023–1029.

    Article  Google Scholar 

  9. Seethala RR, Baloch ZW, Barletta JA, Khanafshar E, Mete O, Sadow PM, LiVolsi VA, Nikiforov YE, Tallini G, Thompson LDR Noninvasive follicular thyroid neoplasm with papillary-like nuclear features: a review for pathologists. Mod Pathol. 2018;31(1):39–55.

    Article  CAS  Google Scholar 

  10. Pedrazzini L, Baroli A, Marzoli L, Guglielmi R, Papini E. Cancer recurrence in papillary thyroid microcarcinoma: a multivariate analysis on 231 patients with a 12-year follow-up. Minerva Endocrinol. 2013;38(3):269–279.

    CAS  PubMed  Google Scholar 

  11. Ardito G, Avenia N, Giustozzi E, Salvatori M, Fadda G, Ardito F, Revelli L Papillary thyroid microcarcinoma: proposal of treatment based on histological prognostic factors evaluation. Ann Ital Chir. 2014;85(1):1–5.

    PubMed  Google Scholar 

  12. Wang TS, Goffredo P, Sosa JA, Roman SA. Papillary thyroid microcarcinoma: an over-treated malignancy? World J Surg. 2014;38(9):2297–2303.

    Article  Google Scholar 

  13. Rosai J, LiVolsi VA, Sobrinho-Simoes M, Williams ED. Renaming papillary microcarcinoma of the thyroid gland: the Porto proposal. Int J Surg Pathol. 2003;11(4):249–251.

    Article  Google Scholar 

  14. Nilubol N, Kebebew E. Should small papillary thyroid cancer be observed? A population-based study. Cancer. 2015;121(7):1017–1024.

    Article  Google Scholar 

  15. Ertorer ME, Tutuncu NB, Ozyilkan O. Incidental papillary microcarcinoma of the thyroid. Asian Pac J Cancer Prev. 2007;8(4):631–634.

    PubMed  Google Scholar 

  16. Arora N, Turbendian HK, Kato MA, Moo TA, Zarnegar R, Fahey TJ, III. Papillary thyroid carcinoma and microcarcinoma: is there a need to distinguish the two? Thyroid. 2009;19(5):473–477.

    Article  Google Scholar 

  17. Vasileiadis I, Karatzas T, Vasileiadis D, Kapetanakis S, Charitoudis G, Karakostas E, Kouraklis G Clinical and pathological characteristics of incidental and nonincidental papillary thyroid microcarcinoma in 339 patients. Head Neck. 2014;36(4):564–570.

    Article  Google Scholar 

  18. Mehanna H, Al-Maqbili T, Carter B, Martin E, Campain N, Watkinson J, et al. Differences in the recurrence and mortality outcomes rates of incidental and nonincidental papillary thyroid microcarcinoma: a systematic review and meta-analysis of 21 329 person-years of follow-up. J Clin Endocrinol Metab. 2014;99(8):2834–2843.

    Article  CAS  Google Scholar 

  19. Thompson LD. Ninety-four cases of encapsulated follicular variant of papillary thyroid carcinoma: A name change to Noninvasive Follicular Thyroid Neoplasm with Papillary-like Nuclear Features would help prevent overtreatment. Mod Pathol. 2016;29(7):698–707.

    Article  CAS  Google Scholar 

  20. Johnson DN, Furtado LV, Long BC, Zhen CJ, Wurst M, Mujacic I, Kadri S, Segal JP, Antic T, Cipriani NA Noninvasive Follicular Thyroid Neoplasms With Papillary-Like Nuclear Features (NIFTPs) Are Genetically and Biologically Similar to Adenomatous Nodules and Distinct From Papillary Thyroid Carcinomas With Extensive Follicular Growth. Arch Pathol Lab Med. 2018, 142, 838, 850.

    Article  Google Scholar 

  21. Hirokawa M, Higuchi M, Suzuki A, Hayashi T, Kuma S, Miyauchi A. Noninvasive follicular thyroid neoplasm with papillary-like nuclear features: a single-institutional experience in Japan. Endocr J. 2017;64(12):1149–1155.

    Article  Google Scholar 

  22. Song SJ, LiVolsi VA, Montone K, Baloch Z. Pre-operative features of non-invasive follicular thyroid neoplasms with papillary-like nuclear features: An analysis of their cytological, Gene Expression Classifier and sonographic findings. Cytopathology. 2017;28(6):488–494.

    Article  CAS  Google Scholar 

  23. Kim M, Kim JE, Kim HJ, Chung YR, Kwak Y, Park SY. Cytologic Diagnosis of Noninvasive Follicular Thyroid Neoplasm with Papillary-like Nuclear Features and Its Impact on the Risk of Malignancy in the Bethesda System for Reporting Thyroid Cytopathology: An Institutional Experience. J Pathol Transl Med. 2018;52(3):171–178.

    Article  Google Scholar 

  24. Maletta F, Massa F, Torregrossa L, Duregon E, Casadei GP, Basolo F, Tallini G, Volante M, Nikiforov YE, Papotti M Cytological features of “noninvasive follicular thyroid neoplasm with papillary-like nuclear features” and their correlation with tumor histology. Hum Pathol. 2016;54:134–142.

    Article  CAS  Google Scholar 

  25. Sahli ZT, Umbricht CB, Schneider EB, Zeiger MA. Thyroid Nodule Diagnostic Markers in the Face of the New NIFTP Category: Time for a Reset? Thyroid. 2017;27(11):1393–1399.

    Article  Google Scholar 

  26. Samulski TD, LiVolsi VA, Wong LQ, Baloch Z. Usage trends and performance characteristics of a “gene expression classifier” in the management of thyroid nodules: An institutional experience. Diagn Cytopathol. 2016;44(11):867–873.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pathology and Laboratory Medicine, Hospital of the University of Pennsylvania, 6 Founders, 3400 Spruce Street, Philadelphia, PA, 19104, USA

    Khurram Shafique, Virginia A. LiVolsi, Kathleen Montone & Zubair W. Baloch

Authors
  1. Khurram Shafique
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Virginia A. LiVolsi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Kathleen Montone
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Zubair W. Baloch
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Khurram Shafique.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Shafique, K., LiVolsi, V.A., Montone, K. et al. Papillary Thyroid Microcarcinoma: Reclassification to Non-Invasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features (NIFTP): a Retrospective Clinicopathologic Study. Endocr Pathol 29, 339–345 (2018). https://doi.org/10.1007/s12022-018-9546-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12022-018-9546-3

Keywords

Search

Navigation